Evidence map›Paper›PMID 31551445›Full record

ArticleScientific reports2019

High-Throughput Automated Microscopy of Circulating Tumor Cells.

Carlos Aguilar-Avelar, Brenda Soto-García, Diana Aráiz-Hernández, Juan F Yee-de León, Miguel Esparza, Franco Chacón, Jesús Rolando Delgado-Balderas, Mario M Alvarez, Grissel Trujillo-de Santiago, Lauro S Gómez-Guerra and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Updates on "Cancer Genomics and Epigenomics".World journal of clinical oncology · 2020
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carlos Aguilar-AvelarDelee Corp., Mountain View, CA, 94041, USA.
Brenda Soto-GarcíaDelee Corp., Mountain View, CA, 94041, USA.
Diana Aráiz-HernándezDelee Corp., Mountain View, CA, 94041, USA.
Juan F Yee-de LeónDelee Corp., Mountain View, CA, 94041, USA.
Miguel EsparzaDelee Corp., Mountain View, CA, 94041, USA.
Franco ChacónDelee Corp., Mountain View, CA, 94041, USA.
Jesús Rolando Delgado-BalderasDepartamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, 64460, Mexico.ORCID http://orcid.org/0000-0002-9016-2016
Mario M AlvarezCentro de Biotecnología-FEMSA, Escuela de Ingeniería y Ciencias, Tecnologico de Monterrey, Monterrey, 64849, Mexico.
Grissel Trujillo-de SantiagoCentro de Biotecnología-FEMSA, Escuela de Ingeniería y Ciencias, Tecnologico de Monterrey, Monterrey, 64849, Mexico.
Lauro S Gómez-GuerraServicio de Urología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, 64460, Mexico.
Liza P Velarde-CalvilloDelee Corp., Mountain View, CA, 94041, USA.
Alejandro Abarca-BlancoDelee Corp., Mountain View, CA, 94041, USA. alejandro@delee.bio.
J D Wong-CamposDelee Corp., Mountain View, CA, 94041, USA. jwongcam@umd.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) have the potential of becoming the gold standard marker for cancer diagnosis, prognosis and monitoring. However, current methods for its isolation and characterization suffer from equipment variability and human operator error that hinder its widespread use. Here we report the design and construction of a fully automated high-throughput fluorescence microscope that enables the imaging and classification of cancer cells that were labeled by immunostaining procedures. An excellent agreement between our machine vision-based approach and a state-of-the-art microscopy equipment was achieved. Our integral approach provides a path for operator-free and robust analysis of cancer cells as a standard clinical practice.

Indexed as

Biomarkers, TumorCell CountCell Line, TumorCell SeparationHumansMicroscopy, FluorescenceNeoplastic Cells, CirculatingPrognosisBiomarkers, Tumor

Identifiers

PMID31551445
PMCPMC6760523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.